Purinergic Signal
Purinergic Signalling
1573-9538
1573-9546
Springer Netherlands
Dordrecht


2072926
18404446
9066
10.1007/s11302-007-9066-y
Original Paper


2A
 receptors modulate BDNF both in normal conditions and in experimental models of Huntington’s disease

Potenza
R. L.

1

Tebano
M. T.

1

Martire
A.

1

Domenici
M. R.

1

Pepponi
R.

1

Armida
M.

1

Pèzzola
A.

1

Minghetti
L.

2

Popoli
P.

+39-0649902482
+39-0649387104
patrizia.popoli@iss.it

1

1
Department of Therapeutic Research and Medicine Evaluation, Istituto Superiore di Sanità, Viale Regina Elena, 299, 00161 Rome, Italy 
2
Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Viale Regina Elena, 299, 00161 Rome, Italy 

15
9
2007

9
2007

3
4
333
338
1
6
2007

25
7
2007


© Springer Science + Business Media B.V. 2007

2A
2A
2A
2A
2A
2A
2A
2A
2A
2A
Rs are necessary to allow BDNF-induced potentiation of synaptic transmission and to sustain a normal BDNF tone. The possible functional consequences of reducing striatal BDNF levels in HD models need further investigation.

Keywords
2A
 receptors
BDNF levels
Hippocampus
Huntington’s disease
Striatum
Synaptic transmission

issue-copyright-statement
© Springer Science+Business Media B.V. 2007




Introduction
1
3
4
5
6
7
10
11
12
13
14
].
2A
2A
15
16
2A
Rs facilitate the excitatory action of BDNF on hippocampal synaptic transmission.
17
18
19
21
Bdnf
20
21
22
].
2A
23
24
2A
25
2A
24
2A
2A
Rs seem to be implicated in HD.
2A
2A
2A
R blockade on striatal BDNF levels in experimental models of HD or HD-like striatal degeneration.
2A
R
26
1
2A
2A
2A
Fig. 1
2A
2A
P
t
 test)




17
27
28
2A
2A
2A
R KO mice were used.

2A
 KO mice
2A
2A
-/-
29
2A
1
2A
2A
2A
2A
R KO mice is not associated with a reduced density of TrkB receptors.

2A
R KO vs. WT mice
2A
2A
2
2A
Fig. 2
2A
2A
P
 < 0.05 vs. WT




2A
2A
2A
30
31
32
33
2A
2A
 agonist CGS 21680.
2A
2A
2A
34
35
2A
2A
36
2A
37
2A
2A
38
2A
2A
Rs and BDNF.

2A
Rs regulate striatal BDNF levels in experimental models of HD or HD-like striatal degeneration
39
40
41
3
3
39
Fig. 3
2A
N
P
P
 < 0.05 vs. corresponding vehicle




2A
42
43
2A
4
43
44
2A
45
2A
2A
46
Fig. 4
2A
N
P
t
 test)




2A
4
2A
Rs significantly reduces striatal BDNF levels in experimental models of HD or HD-like neurodegeneration, this does not seem to have a negative impact on the course of the disease. Of course, it is still possible that reducing BDNF levels at other time points of the pathological process has a much marked influence on the disease. This issue, as well as the evaluation of BDNF protein changes at different stages of the disease, will be the object of future studies.


Conclusions
47
2A
16
48
2A
2A
2A
2A
2A
2A
2A
Rs in the regulation of BDNF levels is also evident in experimental models of HD (R6/2 mice) and of HD-like striatal degeneration (QA lesion in rats).
42
43
2A
24
].


References
1.
Vicario-Abejón
C

Owens
D

McKay
R



Role of neurotrophins in central synapse formation and stabilization
Nat Rev Neurosci
2002
3
965
974
10.1038/nrn988

12461553


2.
Huang
EJ

Reichardt
LF


Neurotrophins: roles in neuronal development and function
Annu Rev Neurosci
2001
24
677
736
10.1146/annurev.neuro.24.1.677

11520916


3.
Kalb
R


The protean actions of neurotrophins and their receptors on the life and death of neurons
Trends in Neurosciences
2005
28
5
11
10.1016/j.tins.2004.11.003

15626491


4.
Schmidt-Kastner
R

Wetmore
C

Olson
L


Comparative study of brain-derived neurotrophic factor messenger RNA and protein at cellular level suggests multiple roles in hippocampus, striatum and cortex
Neuroscience
1996
74
161
183
10.1016/0306-4522(96)00093-0

8843085


5.
Conner
JM

Lauterborn
JC

Yan
Q



Distribution of brain derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport
J Neurosci
1997
17
2295
2313

9065491


6.
Lu
B


BDNF and activity-dependent synaptic modulation
Learn Mem
2003
10
86
98
10.1101/lm.54603

12663747


7.
Figurov
A

Pozzo-Miller
LD

Olafsson
P



Regulation of synaptic responses to high frequency stimulation and LTP by neurotrophins in the hippocampus
Nature
1996
381
706
709
10.1038/381706a0

8649517


8.
Korte
M

Carroll
P

Wolf
E



Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor
Proc Natl Acad Sci USA
1995
92
8856
8860
10.1073/pnas.92.19.8856

7568031


9.
Korte
M

Griesbeck
O

Gravel
C



Virus-mediated gene transfer into hippocampal CA1 region restores long term potentiation in brain derived neurotrophic factor mutant mice
Proc Natl Acad Sci USA
1996
93
12547
12552
10.1073/pnas.93.22.12547

8901619


10.
Patterson
SL

Abel
T

Deuel
TA



Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice
Neuron
1996
16
1137
1145
10.1016/S0896-6273(00)80140-3

8663990


11.
Bramham
CR

Messaoudi
E


BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis
Prog Neurobiol
2005
76
99
125
10.1016/j.pneurobio.2005.06.003

16099088


12.
Nagappan
G

Lu
B


Activity-dependent modulation of the BDNF receptor TrkB: mechanisms and implications
Trends Neurosc
2005
28
464
471
10.1016/j.tins.2005.07.003

Nagappan G, Lu B (2005) Activity-dependent modulation of the BDNF receptor TrkB: mechanisms and implications. Trends Neurosc 28:464–471 

13.
Canals
J.M

Checa
N.

Marco
S.


The neurotrophin receptors trkA, trkB and trkC are differentially regulated after excitotoxic lesion in rat striatum
Brain Res Mol Brain Res
1999
69
242
248
10.1016/S0169-328X(99)00130-8

10366745


14.
Checa
N

Canals
JM

Gratacos
E


TrkB and TrkC are differentially regulated by excitotoxicity during development of the basal ganglia
Exp Neurol
2001
172
282
292
10.1006/exnr.2001.7796

11716553


15.
Lee
FS

Chao
MV


Activation of trk neurotrophin receptors in the absence of neurotrophins
Proc Natl Acad Sci USA
2001
98
3555
3560
10.1073/pnas.061020198

11248116


16.
Diogenes
MJ

Fernandes
CC

Sebastião
AM


2A
 receptor facilitates brain-derived neurotrophic factor modulation of synaptic transmission in hippocampal slices
J Neurosci
2004
24
2905
2913
10.1523/JNEUROSCI.4454-03.2004

15044529


17.
Cattaneo
E

Zuccato
C

Tartari
M


Normal Huntingtin function: an alternative approach to Huntington’s disease
Nat Rev Neurosci
2005
6
919
930
10.1038/nrn1806

16288298


18.
Zuccato
C

Cattaneo
E


Role of brain-derived neurotrophic factor in Huntington’s disease
Prog Neurobiol
2007
81
294
330
10.1016/j.pneurobio.2007.01.003

17379385


19.
Hodgson
JG

Agopyran
N

Gutekunst
CA



A YAC mouse model for Huntington’s disease with full-length mutant Huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration
Neuron
1999
23
181
192
10.1016/S0896-6273(00)80764-3

10402204


20.
Zuccato
C

Ciammola
A

Rigamonti
D



Loss of Huntingtin-mediated BDNF gene transcription in Huntington’s disease
Science
2001
293
493
498
10.1126/science.1059581

11408619


21.
Zuccato
C

Tartari
M

Crotti
A



Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes
Nat Genet
2003
35
76
83
10.1038/ng1219

12881722


22.
Bemelmans
AP

Horellou
P

Pradier
L



Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington’s disease, as demonstrated by adenoviral gene transfer
Hum Gene Ther
1999
10
2987
2997
10.1089/10430349950016393

10609659


23.
Blum
D

Hourez
R

Galas
MC



Adenosine receptors and Huntington’s disease: implications for pathogenesis and therapeutics
Lancet Neurol
2003
2
366
374
10.1016/S1474-4422(03)00411-3

12849153


24.
Popoli
P

Blum
D

Martire
A



Functions, dysfunctions and therapeutic potential of adenosine A2A receptors in Huntington’s diseases
Prog Neurobiol
2007
81
5–6
331
348
10.1016/j.pneurobio.2006.12.005

17303312


25.
Glass
M

Dragunow
M

Faull
RLM


The pattern of neurodegeneration in Huntington’s disease: a comparative study of cannabinoid, dopamine adenosine and GABAA receptor alterations in the human basal ganglia in Huntington’s disease
Neuroscience
2000
97
505
519
10.1016/S0306-4522(00)00008-7

10828533


26.
Tebano
MT

Martire
A

Rebola
N



Adenosine A2A receptors and metabotropic glutamate 5 receptors are co-localized and functionally interact in the hippocampus: a possible key mechanism in the modulation of N-methyl-D-aspartate effects
J Neurochem
2005
95
1188
1200
10.1111/j.1471-4159.2005.03455.x

16271052


27.
Poo
M


Neurotrophins as synaptic modulators
Nature
2001
2
24
32

Poo M (2001) Neurotrophins as synaptic modulators. Nature 2:24–32 

28.
Suzuki
S

Numakawa
T

Shimazu
K



BDNF-induced recruitment of TrkB receptor into neuronal lipid rafrs: roles in synaptic modulation
J Cell Biol
2004
167
1205
1215
10.1083/jcb.200404106

15596541


29.
Chen
JF

Huang
Z

Ma
J

Zhu
J



A2A adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice
J Neurosci
1999
19
9192
9200

10531422


30.
Boulanger
L

Poo
MM


Gating of BDNF-induced synaptic potentiation by cAMP
Science
1999
284
1982
1984
10.1126/science.284.5422.1982

10373115


31.
Fang
H

Chartier
J

Sodja
C



Transcriptional activation of the human brain-derived neurotrophic factor gene promoter III by dopamine signalling in NT2/N neurons
J Biol Chem
2003
278
26401
26409
10.1074/jbc.M211539200

12738784


32.
Patterson
SL

Pittenger
C

Morozov
A



Some forms of cAMP-mediated long-lasting potentiation are associated with release of BDNFand nuclear translocation of phosphoMAP kinase
Neuron
2001
32
123
140
10.1016/S0896-6273(01)00443-3

11604144


33.
Kolarow R, Brigadski T, Lessmann V (2006) Intracellular targeting of neurotrophins and signalling cascades involved in synaptic secretion of BDNF and NT3. Society for Neurosci, Annual Meeting, Atlanta USA, 14–18 October 2006

34.
Tyler
WJ

Alonso
M

Bramhan
CR

Pozzo-Miller
LD


From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning
Learn Mem
2002
9
224
237
10.1101/lm.51202

12359832


35.
Heldt
SA

Stanek
L

Chatwal
JP

Ressler
KJ


Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories
Mol Psychiatry
2007
12
656
670
10.1038/sj.mp.4001957

17264839


36.
Wang
JH

Ma
YY

Buuse
M


2A
 receptors
Exp Neurol
2006
199
438
445
10.1016/j.expneurol.2006.01.005

16519887


37.
Gimenez-Llort
L

Schiffmann
SN

Shmidt
T



Working memory deficits in transgenic rats overexpressing human adenosine A2A receptors in the brain
Neurobiol Learn Mem
2007
87
42
56
10.1016/j.nlm.2006.05.004

16824773


38.
Diogenes
JM

Assaife-Lopes
N

Pinto-Duarte
A

Ribeiro
JA

Sebastiao
A


Influence of age on BDNF modulation of hippocampal synaptic transmission: interplay with adenosine A2A receptors
Hippocampus
2007
17
577
585
10.1002/hipo.20294

17421024


39.
Popoli
P

Pintor
A

Domenici
MR



2A
 receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum
J Neurosci
2002
22
1967
1975

11880527


40.
Mangiarini
L

Sathasivam
K

Seller
M



Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
Cell
1996
87
493
506
10.1016/S0092-8674(00)81369-0

8898202


41.
Minghetti
L

Greco
A

Potenza
RL



Effects of the adenosine A2A receptors antagonist SCH 58261 on cyclooxygenase-2 expression, glial activation and BDNF avaibility in a rat model of striatal neurodegeneration
J Neuropathol Exp Neurol
2007
66
363
371

17483693


42.
Lynch
G

Kramar
EA

Rex
CS



Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington’s disease
J Neurosci
2007
27
4424
4434
10.1523/JNEUROSCI.5113-06.2007

17442827


43.
Zuccato
C

Liber
D

Ramos
C



Progressive loss of BDNF in a mouse model of Huntington’s disease and rescue by BDNF delivery
Pharmacol Res
2005
52
133
139
10.1016/j.phrs.2005.01.001

15967378


44.
Pang
TYC

Stam
NC

Nithianantharajah
J



Differential effects of voluntary physical exercise on behavioural and brain-derived neurotrophic factor expression deficits in Huntington’s disease transgenic mice
Neuroscience
2006
141
569
584
10.1016/j.neuroscience.2006.04.013

16716524


45.
Cha
JH

Frey
AS

Alsdorf
SA



Altered neurotransmitter receptor expression in transgenic mouse models of Huntington’s disease, Philos. Trans. R. Soc. Lond
B Biol Sci
1999
354
981
989

Cha JH, Frey AS, Alsdorf SA et al (1999) Altered neurotransmitter receptor expression in transgenic mouse models of Huntington’s disease, Philos. Trans. R. Soc. Lond. B Biol Sci 354 981–989 

46.
Tarditi
A

Camurri
A

Varani
K



2A
) receptor signaling in a mouse model of Huntington disease
Neurobiol Dis
2006
23
44
53
10.1016/j.nbd.2006.01.014

16651003


47.
Kovalchuk
Y

Holthoff
K

Konnerth
A


Neurotrophin action on a rapid timescale
Current Opinion in Neurobiol
2004
14
558
563
10.1016/j.conb.2004.08.014

Kovalchuk Y, Holthoff K, Konnerth A (2004) Neurotrophin action on a rapid timescale. Current Opinion in Neurobiol 14:558–563 

48.
Pousinha
PA

Diogenes
MJ

Ribeiro
JA



2A
 receptors
Neurosci Lett
2006
404
143
147
10.1016/j.neulet.2006.05.036

16790314





